Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05109104 · ClinicalTrials.gov registry record · NA

Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products

A NA study of Sunscreening Agents, sponsored by HALEON.

Completed
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT05109104 is a NA study of Sunscreening Agents that has completed, run by HALEON. The registered enrollment target is 13 participants, below the 81-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05109104, a NA study of Sunscreening Agents, has completed, sponsored by HALEON.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the static SPF of three sunscreen products (ChapStick Active Performance \[CAP\] UnScented, CAP Herbal Mint and CAP Mountain Berry) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011).

Conditions Studied

Interventions

  • DRUG CAP UnScented
  • DRUG CAP Herbal Mint
  • DRUG CAP Mountain Berry
  • DRUG SPF Standard Sunscreen

Study Locations (1)

North Carolina

  • GSK Investigational Site - Winston-Salem

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2021-11-08
Est. Completion 2021-12-15
Phase NA

Sponsor

HALEON

34 total trials

What the Registry Record Tells You About NCT05109104

The ClinicalTrials.gov registry entry for NCT05109104 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 81-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (84% lower). The listed sponsor is HALEON, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sunscreening Agents appearing as the primary indexed condition, and to 4 interventions - of which CAP UnScented is the first listed.

NCT05109104 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05109104 about?

NCT05109104 is a clinical study titled "Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products". The purpose of this study is to determine the static SPF of three sunscreen products (ChapStick Active Performance \[CAP\] UnScented, CAP Herbal Mint and CAP Mountain Berry) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011).

What is the current status of trial NCT05109104?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2021-11-08. Estimated completion is 2021-12-15.

What conditions does trial NCT05109104 study?

This clinical trial studies the following conditions: Sunscreening Agents.

What interventions are being tested in trial NCT05109104?

The interventions under investigation include: CAP UnScented (DRUG), CAP Herbal Mint (DRUG), CAP Mountain Berry (DRUG), SPF Standard Sunscreen (DRUG).

Who is sponsoring clinical trial NCT05109104?

This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05109104 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sunscreening Agents

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.